Provided by Tiger Trade Technology Pte. Ltd.

Repare Therapeutics Inc.

2.22
-0.0150-0.67%
Post-market: 2.13-0.0850-3.84%17:21 EST
Volume:134.94K
Turnover:298.58K
Market Cap:95.21M
PE:-1.31
High:2.23
Open:2.22
Low:2.20
Close:2.23
52wk High:4.07
52wk Low:0.8900
Shares:42.99M
Float Shares:22.72M
Volume Ratio:0.49
T/O Rate:0.59%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6944
EPS(LYR):-1.9969
ROE:-49.78%
ROA:-29.72%
PB:0.83
PE(LYR):-1.11

Loading ...

Repare Therapeutics Inc. Announces Date for Upcoming Special Shareholder Meeting

Reuters
·
Dec 04

BRIEF-Repare Signs Support Agreements With Key Shareholders For Xenotherapeutics Deal

Reuters
·
Nov 21

Repare Therapeutics Secures Major Shareholder Support for XenoTherapeutics Deal

Reuters
·
Nov 21

Repare Therapeutics Enters Into Support and Voting Agreements With Significant Shareholders for Proposed Transaction With Xenotherapeutics, Inc.

THOMSON REUTERS
·
Nov 21

Repare Therapeutics Reports Positive Q3 2025 Results

TIPRANKS
·
Nov 20

Repare Therapeutics Agrees To Acquisition As Board Cites Best Path For Stakeholder Value

Benzinga_recent_news
·
Nov 17

Repare Therapeutics Announces Acquisition by XenoTherapeutics

TIPRANKS
·
Nov 17

TD Cowen Downgrades Repare Therapeutics to Hold From Buy

MT Newswires Live
·
Nov 17

TD Cowen downgrades Repare Therapeutics (RPTX) to a Hold

TIPRANKS
·
Nov 17

Stocks to Watch: Taitron, Repare Therapeutics

Dow Jones
·
Nov 15

Repare Therapeutics to be Acquired by XenoTherapeutics in Strategic Move

TIPRANKS
·
Nov 15

Repare Therapeutics trading resumes

TIPRANKS
·
Nov 15

XenoTherapeutics to acquire Repare Therapeutics for $1.82 p/s plus one CVR

TIPRANKS
·
Nov 15

Repare Therapeutics Q3 EPS $0.08 Beats $(0.12) Estimate, Sales $11.620M Beat $7.500M Estimate

Benzinga
·
Nov 15

XenoTherapeutics to Acquire Repare Therapeutics for $1.82 Per Share Plus CVR

Reuters
·
Nov 15

Repare Therapeutics Inc - Shareholders Estimated to Receive $1.82 per Share

THOMSON REUTERS
·
Nov 15

Repare Therapeutics Enters Into Definitive Agreement to Be Acquired by Xenotherapeutics, Inc.

THOMSON REUTERS
·
Nov 15

Repare Therapeutics’ Promising Study on Advanced Solid Tumors: A Closer Look

TIPRANKS
·
Oct 28

Repare Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Oct 27

Repare Therapeutics Inc. : H.c. Wainwright Cuts Target Price to $3 From $5

THOMSON REUTERS
·
Oct 27